Glucocorticoids and laminitis in the horse

Veterinary Clinics of North America - Equine Practice

Volumn 18, Issue 2, 2002, Pages 219-236

  Johnson, Philip J ^a   Slight, Simon H ^a   Ganjam, Venkataseshu K ^a   Kreeger, John M ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EQUIDAE;

11BETA HYDROXYSTEROID DEHYDROGENASE; GLUCOCORTICOID;

ANIMAL; ANIMAL DISEASE; ANIMAL LAMENESS; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; FOOT DISEASE; HOOF AND CLAW; HORSE; HORSE DISEASE; INFLAMMATION; MALE; METABOLISM; PATHOLOGY; REVIEW; RISK FACTOR;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; FEMALE; FOOT DISEASES; GLUCOCORTICOIDS; HOOF AND CLAW; HORSE DISEASES; HORSES; INFLAMMATION; LAMENESS, ANIMAL; MALE; RISK FACTORS;

EID: 1642432166     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0739(02)00015-9     Document Type: Review

References (72)

1. Ganong W.F. Review of medical physiology. 20th ed. (2001), Lange Medical Books, McGraw-Hill, New York p. 358-62
2. Harkins J.D., Carney J.M., and Tobin T. Clinical use and characteristics of the corticosteroids. Vet Clin Equine 9 (1993) 543-562
3. Lawrence R., Fessler J.F., Gall C.M., et al. Clinical forum: questions and answers. Steroid-induced laminitis. Equine Pract 7 (1985) 31-32
4. Lose M.P. Drug-induced laminitis in a colt. Mod Vet Pract 61 (1980) 608-610
5. Vernimb G.D., Van Hoose L.M., and Hennessey P.W. Onset and duration of corticosteroid effect after injection of betasone for treating equine arthropathies. Vet Med Small Anim Clin 72 (1977) 241-244
6. Guyton A.C., and Hall J.E. Textbook of medical physiology. 9th ed. (1996), WB Saunders Co, Philadelphia p. 962-70
7. Sapolsky R.M., Romero L.M., and Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparatory actions. Endocr Rev 21 (2000) 55-89
8. Johnson P.J. The equine metabolic syndrome: peripheral Cushing's syndrome. Vet Clin Equine 18 (2002) 219-241
9. MacKay R.J. Endotoxemia. In: Smith B.P. (Ed). Large animal internal medicine. 3rd ed. (2002), Mosby, St. Louis (MO) 633-641
10. Bone R.C. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 125 (1996) 680-687
11. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 50 (1932) 137-195
12. Schott H. Pituitary pars intermedia dysfunction: equine Cushing's disease. Vet Clin Equine 18 (2002) 243-275
13. Bijlsma J.W. Prevention of glucocorticoid induced osteoporosis. Ann Rheum Dis 56 (1997) 507-509
14. Brem A.S., Bina R.B., Mehta S., et al. Glucocorticoids inhibit the expression of calcium-dependent potassium channels in vascular smooth muscle. Mol Genet Metab 67 (1999) 53-57
15. Brem A.S. Insights into glucocorticoid-associated hypertension. Am J Kidney Dis 37 (2001) 1-10
16. Hood D.M., Stephens K.A., Amoss M.S., et al. The effect of exogenous steroid on the carbohydrate overload model of equine laminitis: a preliminary report. Proceed Am Assoc Practic Newslett 2 (1982) 149-151
17. Slone D.E., Purohit R.C., and Ganjam V.K. Corticosteroid effects in bilaterally adrenalectomized and intact horses. Proceedings of the first equine endotoxemia-laminitis symposium (1981), University of Missouri, Columbia (MO) 130-135
18. Coughlan A.R., Robertson D.H., Bennett D., et al. Matrix metalloproteinases 2 and 9 in canine rheumatoid arthritis. Vet Rec 143 (1998) 219-223
19. Dschietzig T., Richter C., Pfannenschmidt G., et al. Dexamethasone inhibits stimulation of pulmonary endothelins by proinflammatory cytokines: possible involvement of a nuclear factor kappa B dependent mechanism. Intensive Care Med 27 (2001) 751-756
20. Johnson P.J., Tyagi S.C., Katwa L.C., et al. Activation of extracellular matrix metalloproteinases in equine laminitis. Vet Rec 142 (1998) 392-396
21. Katwa L.C., Johnson P.J., Ganjam V.K., et al. Expression of endothelin in equine laminitis. Equine Vet J 31 (1999) 243-247
22. Roberts D. Treatment of equine laminitis by intra-arterial infusion of adrenocorticoid steroids. Vet Med Small Anim Clin 60 (1965) 1109-1113
23. Dybdal N. Pituitary pars intermedia dysfunction (equine Cushing's-like disease). In: Robinson N.E. (Ed). Current therapy in equine medicine. 4th ed. (1997), WB Saunders Co, Philadelphia 449-501
24. Allen D.J., Clark E.S., Moore J.N., et al. Evaluation of equine digital Starling forces and hemodynamics during early laminitis. Am J Vet Res 51 (1990) 1930-1934
25. Clarke L.L., Garner H.E., and Hatfield D. Plasma volume, electrolyte, and endocrine changes during onset of laminitis hypertension in horses. Am J Vet Res 43 (1982) 1551-1555
26. Hood D.M., Amoss M.S., Hightower D., et al. Equine laminitis: radioisotopic analysis of hemodynamics of the foot during the acute disease. J Equine Med Surg 2 (1978) 439-444
27. Moore J.N., Garner H.E., Berg J.N., et al. Intracecal endotoxin and lactate during the onset of equine laminitis: a preliminary report. Am J Vet Res 40 (1979) 722-723
28. Moore J.N., Garner H.E., and Coffman J.R. Hematological changes during development of acute laminitis hypertension. Equine Vet J 13 (1981) 240-242
29. Schneider D.A., Parks A.H., Eades S.C., et al. Palmar digital vessel relaxation in normal horses and in horses given carbohydrate. Am J Vet Res 60 (1999) 233-239
30. Weiss D.J., Evanson O.A., McClenahan D., et al. Effect of a competitive inhibitor of platelet aggregation on experimentally induced laminitis in ponies. Am J Vet Res 59 (1998) 814-817
31. Mungall B.A., Kyaw-Tanner M., and Pollitt C.C. In vitro evidence for a bacterial pathogenesis of equine laminitis. Vet Microbiol 79 (2001) 209-223
32. Mungall B.A., and Pollitt C.C. Zymographic analysis of equine laminitis. Histochem Cell Biol 112 (1999) 467-472
33. Hood D.M., Grosenbaugh D.A., Mostafa M.B., et al. The role of vascular mechanisms in the development of acute equine laminitis. J Vet Intern Med 7 (1993) 228-234
34. Fontaine G.L., Belknap J.K., Allen D., et al. Expression of interleukin-1beta in the digital laminae of horses in the prodromal stage of experimentally induced laminitis. Am J Vet Res 62 (2001) 714-720
35. French K., Pollitt C.C., and Pass M.A. Pharmacokinetics and metabolic effects of triamcinolone acetonide and their possible relationships to glucocorticoid-induced laminitis. J Vet Pharmacol Ther 23 (2000) 287-292
36. Eyre P., Elmes P.J., and Strickland S. Corticosteroid-potentiated vascular responses of the equine digit: a possible pharmacologic basis for laminitis. Am J Vet Res 40 (1979) 135-138
37. Ross E.J., and Linch D.C. Cushing's syndrome-killing disease. Discriminatory value of signs and symptoms aiding early diagnosis. Lancet ii (1982) 646-649
38. McCoy B.J., Diegelmann R.F., and Cohen I.K. In vitro inhibition of cell growth, collagen biosynthesis and prolylhydroxylane activity by triamcinalone acetonide. Proc Soc Exp Biol Med 153 (1980) 216-222
39. Bitar M.S. Insulin and glucocorticoid-dependent suppression of the IGF-I system in diabetic wounds. Surgery 127 (2000) 687-695
40. Groves R.W., MacDonald L.M., and MacDonald D.M. Profound digital collagen atrophy: a new cutaneous presentation of adrenal-dependent Cushing's syndrome. Br J Dermatol 123 (1990) 667-671
41. Pollitt C.C. Basement membrane pathology: a feature of acute laminitis. Equine Vet J 28 (1996) 38-46
42. Angeli A., Masera R.G., Sartori M.L., et al. Modulation by cytokines of glucocorticoids action. Ann N Y Acad Sci 876 (1999) 210-220
43. Serres M., Viac J., and Schmitt D. Glucocorticoid receptor localization in human epidermal cells. Arch Dermatol Res 288 (1996) 140-146
44. Gras M.P., Verrecchia F., Uitto J., et al. Downregulation of human type VII collagen (COL7A1) promoter activity by dexamethasone. Identification of a glucocorticoid receptor binding region. Exp Dermatol 10 (2001) 28-34
45. Hendry K.A., MacCallum A.J., Knight C.H., et al. Effect of endocrine and paracrine factors on protein synthesis and cell proliferation in bovine hoof tissue culture. J Dairy Res 66 (1999) 23-33
46. Beer H.D., Fassler R., and Werner S. Glucocorticoid-regulated gene expression during cutaneous wound repair. Vitam Horm 59 (2000) 217-239
47. Chedid M., Hoyle J.R., Csaky K.G., et al. Glucocorticoids inhibit keratinocyte growth factor production in primary dermal fibroblasts. Endocrinology 137 (1996) 2232-2237
48. Pass M.A., Pollitt S., and Pollitt C.C. Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis?. Equine Vet J 26 (1998) 133-138
49. Davies N.M., Wright M.R., and Jamali F. Anti-inflammatory drug-induced small intestinal permeability: the rat is a suitable model. Pharm Res 11 (1994) 1652-1656
50. Kiziltas S., Imeryuz N., Gurcan T., et al. Corticosteroid therapy augments gastroduodenal permeability to sucrose. Am J Gastroenterol 93 (1998) 2420-2425
51. Meddings J.B., and Swain M.G. Environmental stress-induced gastrointestinal permeability is mediated by endogenous glucocorticoids in the rat. Gastroenterology 119 (2000) 1019-1028
52. Soderholm J.D., and Perdue M.H. Stress and gastrointestinal tract. II. Stress and intestinal barrier function. Am J Physiol [Gastrointest Liver Physiol] 280 (2001) G7-G13
53. Garner H.E., Coffman J.R., Hahn A.W., et al. Equine laminitis of alimentary origin: an experimental model. Am J Vet Res 36 (1975) 441-444
54. Gennari C. Glucocorticoid induced osteoporosis. Clin Endocrinol (Oxf) 41 (1994) 273-274
55. Sandeep T.C., and Walker B.R. Pathophysiology of modulation of local glucocorticoid levels by 11β-hydroxysteroid dehydrogenases. Trends Endocrinol Metabol 12 (2001) 446-453
56. Penning T.M. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr Rev 18 (1997) 281-305
57. White P.C., Mune T., and Agarwal A.K. 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocrinol Rev 18 (1997) 135-156
58. Edwards C.R.W., Stewart P.M., Nairn I.M., et al. Cushing's disease of the kidney. J Endocrinol 104-S (1985) 53
59. Shackleton C.H.L., and Stewart P.M. The hypertension of apparent mineralocorticoid excess (AME) syndrome. In: Biglieri E.G., and Melby J.E. (Eds). Endocrine hypertension (1990), Raven Press, New York 155-173
60. Mune T., Rogerson F.M., Nikkila H., et al. Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nat Genet 10 (1995) 394-399
61. Shackleton C.H.L., Rodriguez J., Arteaga E., et al. Congenital 11β-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension. Corticosteroid metabolite profiles of four patients and their families. Clin Endocrinol 22 (1985) 701-712
62. Ulick S., Levine L.S., Gunczler P., et al. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrin Metab 49 (1979) 757-764
63. Walker B.R., and Edwards C.R.W. 11b-hydroxysteroid dehydrogenase and enzyme-mediated receptor protection: life after liquorice?. Clin Endocrinol 35 (1991) 281-289
64. Seckl J.R. 11β-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?. Front Neuroendocrinol 18 (1997) 49-99
65. Bujalska I., Kumar S., and Stewart P.M. Does central obesity reflect "Cushing's disease of the omentum"?. Lancet 349 (1997) 1210-1213
66. Mune T., and White P.C. Apparent mineralocorticoid excess: genotype is correlated with biochemical phenotype. Hypertension 27 (1996) 1193-1199
67. Murphy B.E.P., Clark S.J., Donald I.R., et al. Conversion of maternal cortisol to cortisone during placental transfer to the human fetus. Am J Obstet Gynecol 118 (1974) 538-541
68. Stewart P.M., Murry B.A., and Mason J.I. Type 2 11β-hydroxysteroid dehydrogenase in human fetal tissues. J Clin Endocrinol Metab 78 (1994) 1529-1532
69. Seckl J.R. Glucocorticoids, feto-placental 11β-hydroxysteroid dehydrogenase-2 and the early life origins of adult disease. Steroids 62 (1997) 89-94
70. Lindsay R.S., Lindsay R.M., Waddell B., et al. Programming of glucose tolerance in the rat: role of placental 11β-hydroxysteroid dehydrogenase. Diabetologia 39 (1996) 1299-1305
71. Chavette P, Rossdale PD, Tait AD. 11β-Hydroxysteroid dehydrogenase in equine placenta. Proceedings of the 41st annual AAEP convention; Lexington, KY. December 3-6, 1995. p. 264-5.
72. Allen W.R., Wilsher S., Stewart F., et al. The influence of maternal size on placental, fetal and postnatal growth in the horse. II. Endocrinology of pregnancy. J Endocrinol 172 (2002) 237-246